310 related articles for article (PubMed ID: 15936464)
1. Apolipoprotein e4 allele and the risk of CAD death in type 2 diabetes mellitus with ischaemia electrocardiographic change.
Guang-da X; Xiang-Jiu Y; Lin-Shuang Z; Zhi-Song C; Yu-Sheng H
Diabetes Res Clin Pract; 2005 Jun; 68(3):223-9. PubMed ID: 15936464
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein e4 allele is predictor of coronary artery disease death in elderly patients with type 2 diabetes mellitus.
Guang-da X; You-ying L; Zhi-song C; Yu-sheng H; Xiang-jiu Y
Atherosclerosis; 2004 Jul; 175(1):77-81. PubMed ID: 15186949
[TBL] [Abstract][Full Text] [Related]
3. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
4. Apo e4 allele is associated with endothelium-dependent arterial dilation in women with type 2 diabetes.
Guangda X; Linshuang Z; Jie H; Ling Y; Huijuan X
Diabetes Res Clin Pract; 2006 May; 72(2):155-61. PubMed ID: 16337304
[TBL] [Abstract][Full Text] [Related]
5. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
[TBL] [Abstract][Full Text] [Related]
7. Relationship between severity of coronary artery disease and apolipoprotein E gene polymorphism.
Arslan Ince FD; Atay A; Köseoğlu M; Yeşil M; Deveci E
Anadolu Kardiyol Derg; 2010 Jun; 10(3):202-8. PubMed ID: 20538553
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
Duman BS; Oztürk M; Yilmazer S; Hatemi H
Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
[TBL] [Abstract][Full Text] [Related]
9. Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients.
Kwon MK; Rhee SY; Chon S; Oh S; Woo JT; Kim SW; Kim JW; Kim YS; Jeong KH; Lee SH; Lee TW; Ihm CG
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S228-32. PubMed ID: 17624465
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study.
Srinivasan SR; Ehnholm C; Elkasabany A; Berenson GS
Metabolism; 2001 Jun; 50(6):696-702. PubMed ID: 11398147
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.
Kimura H; Suzuki Y; Gejyo F; Karasawa R; Miyazaki R; Suzuki S; Arakawa M
Am J Kidney Dis; 1998 Apr; 31(4):666-73. PubMed ID: 9531184
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E polymorphism is not associated with lipid levels and coronary artery disease in Greek patients with familial hypercholesterolaemia.
Pitsavos C; Choumerianou DM; Skoumas J; Maumus S; Stefanadis C; Dedoussis GV; Visvikis-Siest S
Clin Exp Med; 2005 Dec; 5(4):196-201. PubMed ID: 16362800
[TBL] [Abstract][Full Text] [Related]
13. [Apolipoprotein E and its alleles in healthy subjects and in atherosclerosis].
Couderc R; Bailleul S
Ann Biol Clin (Paris); 1998; 56(6):651-9. PubMed ID: 9853024
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E phenotype affects the malondialdehyde-modified LDL concentration and forearm endothelial function in postmenopausal women.
Tsuda M; Sanada M; Higashi Y; Hara Y; Kodama I; Chayama K; Yoshizumi M; Ohama K
Clin Endocrinol (Oxf); 2004 Nov; 61(5):619-25. PubMed ID: 15521966
[TBL] [Abstract][Full Text] [Related]
15. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
Tremblay AJ; Bergeron J; Gagné JM; Gagné C; Couture P
Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease.
Tziakas DN; Chalikias GK; Antonoglou CO; Veletza S; Tentes IK; Kortsaris AX; Hatseras DI; Kaski JC
J Am Coll Cardiol; 2006 Dec; 48(12):2471-81. PubMed ID: 17174184
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E polymorphism in type 2 diabetic patients of Talca, Chile.
Leiva E; Mujica V; Orrego R; Prieto M; Arredondo M
Diabetes Res Clin Pract; 2005 Jun; 68(3):244-9. PubMed ID: 15936467
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein e4 allele and endothelium-dependent arterial dilation in Type 2 diabetes mellitus without angiopathy.
Guangda X; Yuhua W
Diabetologia; 2003 Apr; 46(4):514-9. PubMed ID: 12739024
[TBL] [Abstract][Full Text] [Related]
19. Effect of apolipoprotein E polymorphism on renal transplantation.
Cofán F; Cofan M; Rosich E; Campos B; Casals E; Zambon D; Ros E; Oppenheimer F; Campistol JM
Transplant Proc; 2007 Sep; 39(7):2217-8. PubMed ID: 17889142
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E polymorphism and carotid atherosclerosis in patients with coronary disease.
Fernández-Miranda C; Aranda JL; Martín MA; Arenas J; Núñez V; Gómez de la Cámara A
Int J Cardiol; 2004 Apr; 94(2-3):209-12. PubMed ID: 15093983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
